KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Common Equity (2016 - 2025)

CareDx (CDNA) has disclosed Common Equity for 13 consecutive years, with $303.1 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 19.91% to $303.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $303.1 million through Dec 2025, down 19.91% year-over-year, with the annual reading at $303.1 million for FY2025, 19.91% down from the prior year.
  • Common Equity hit $303.1 million in Q4 2025 for CareDx, down from $311.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $479.8 million in Q2 2021 to a low of $256.2 million in Q1 2024.
  • Historically, Common Equity has averaged $381.6 million across 5 years, with a median of $399.7 million in 2023.
  • Biggest five-year swings in Common Equity: skyrocketed 365.11% in 2021 and later tumbled 39.35% in 2023.
  • Year by year, Common Equity stood at $465.9 million in 2021, then fell by 7.51% to $430.9 million in 2022, then crashed by 39.35% to $261.3 million in 2023, then surged by 44.81% to $378.4 million in 2024, then decreased by 19.91% to $303.1 million in 2025.
  • Business Quant data shows Common Equity for CDNA at $303.1 million in Q4 2025, $311.1 million in Q3 2025, and $327.4 million in Q2 2025.